TERT and non-melanoma skin carcinoma: Moreover, careful monitoring of circulating TERT mRNA could be helpful in pre-transplantation to define the minimum non-melanoma skin cancer remission times before the graft, due to the high rate of post-transplant relapse in the patients with pre-transplant skin malignancies (60, 61).